| ACRS |    | Aclaris Therapeutics, Inc. - Common Stock | | | -11.23% -11.23% 0 | | + Immunology, Biopharma, Medicine
Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number | + My List |
| ADTX | | ADiTx Therapeutics, Inc. - Common Stock | | | 0 | | + Immunology, RNA, Medicine
| + My List |
| AFMD | | Affimed N.V. - Common Stock | | | 1.45% down 9.2% -7.75 | | + Immunology, Cancer fight, Medicine
| + My List |
| AGEN | | Agenus Inc. - Common Stock | | | 8.79% 8.79% 0 | | + Cancer fight, Immunology, Medicine
Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities | + My List |
| AKER | | Akers Biosciences Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Pharmaceutical , Immunology, Cancer fight
| + My List |
| ALDX | | Aldeyra Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Immunology, Medicine
| + My List |
| ALEC | | Alector, Inc. - Common Stock | | | 6.26% down 11.73% -5.47 | | + Disease: Neurology/Alzheimer/Parkinson's, Immunology, Medicine
Last highlighted: #ALEC SEC report: Alector, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Alector, Inc. -- SEC File Number | + My List |
| ALT | | Altimmune, Inc. - Common Stock | | | -3.21% down 13.98% -17.19 | | + Immunology, Biopharma, Medicine
Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number | + My List |
| ANAB | | AnaptysBio, Inc. - Common Stock | | | 8.41% 8.41% 0 | | + Immunology, Cancer fight, Medicine
| + My List |
| ANIX | | Anixa Biosciences, Inc. - Common Stock | | | 4.62% up -14.7% 19.32 | | + Cancer fight, Medicine, Immunology
| + My List |
| APVO | | Aptevo Therapeutics Inc. - Common Stock | | | 1.26% down 9.83% -8.57 | | + Biotechnology, Medicine, Disease: Oncology, Immunology
Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab | + My List |
| ARGX | | argenx SE - American Depositary Shares | | | 0.64% 0.64% 0 | | + Immunology, Medicine
| + My List |
| ASLN | | ASLAN Pharmaceuticals Limited - American Depositary Shares | | | 0 | | + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine
Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq | + My List |
| ATHX | | Athersys, Inc. - Common Stock | | | up -7.92% 7.92 | | + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's
| + My List |
| AUPH | | Aurinia Pharmaceuticals Inc - Common Shares | | | down 8.85% -8.85 | | + Pharmaceutical , Immunology, Country: Canada
Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR | + My List |
| AVCO | | Avalon GloboCare Corp. - Common Stock | | | 0 | | + Cancer fight, Medicine, Immunology, Pharmaceutical
Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336 | + My List |
| BLCM | | Bellicum Pharmaceuticals, Inc. - Common Stock | | | 1.82% up -12.6% 14.42 | | + Biopharma, Medicine, Immunology
Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number | + My List |
| BNTX | | BioNTech SE - American Depositary Shares | | | -8.35% -8.35% 0 | | + Biotechnology, Immunology, Covid (fighting), Medicine
Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358 | + My List |
| BTAI | | BioXcel Therapeutics, Inc. - Common Stock | | | 0.37% down 12.65% -12.28 | | + Medicine, Immunology, Artificial Intelligence, Biopharma
| + My List |
| BYSI | | BeyondSpring, Inc. - Ordinary Shares | | | -10.07% -10.07% 0 | | + Cancer fight, Biopharma, Medicine, Immunology
Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR | + My List |
| CABA | | Cabaletta Bio, Inc. - Common Stock | | | -7.92% -7.92% 0 | | + Gene and cell, Medicine, Immunology
| + My List |
| CCXI | | ChemoCentryx, Inc. - Common Stock | | | -4.42% down 8.51% -12.93 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01 | + My List |
| CLDX | | Celldex Therapeutics, Inc. - Common Stock | | | 9.51% 9.51% 0 | | + Cancer fight, Immunology, Medicine
Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052 | + My List |
| CRVS | | Corvus Pharmaceuticals, Inc. - Common Stock | | | down 10.48% -10.48 | | + Medicine, Immunology, Pharmaceutical
| + My List |
| CTSO | | Cytosorbents Corporation - Common Stock | | | -10.38% -10.38% 0 | | + Immunology, Medicine, Surgery
Last highlighted: #CTSO SEC report: Cytosorbents Corp Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Cytosorbents Corp -- SEC File Number 211074173 | + My List |
| CUE | | Cue Biopharma, Inc. - Common Stock | | | -9.67% -9.67% 0 | | + Biopharma, Immunology, Cancer fight
| + My List |
| DBVT | | DBV Technologies S.A. - American Depositary Shares | | | 0.42% down 7.66% -7.24 | | + Immunology, Biopharma, Medicine
Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660 | + My List |
| DVAX | | Dynavax Technologies Corporation - Common Stock | | | -0.48% up -7.27% 6.79 | | + Immunology, Biology, Biopharma, Medicine, Vaccines
Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number | + My List |
| EDSA | | Edesa Biotech, Inc. - Common Shares | | | -1.75% up -8.33% 6.58 | | + Medicine, Biopharma, Immunology
| + My List |
| ENOB | | Enochian Biosciences, Inc. - Common Stock | | | -11.11% -11.11% 0 | | + Disease: Infectious, Cancer fight, Immunology, Medicine
| + My List |
| FATE | | Fate Therapeutics, Inc. - Common Stock | | | 3.72% down 9.1% -5.38 | | + Cancer fight, Immunology, Medicine
| + My List |
| GLSI | | Greenwich LifeSciences, Inc. - Common stock | | | 5.52% down 8.21% -2.69 | | + Medicine, Biopharma, Cancer fight, Immunology
| + My List |
| GNCA | | Genocea Biosciences, Inc. - Common Stock | | | 0 | | + Cancer fight, Immunology, Medicine
| + My List |
| GRTS | | Gritstone Oncology, Inc. - Common Stock | | | 5.58% down 7.17% -1.59 | | + Medicine, Immunology, Cancer fight
| + My List |
| HGEN | | Humanigen, Inc. - Common Stock | | | 6.88% down 7.25% -0.37 | | + Biopharma, Immunology, Cancer fight, Medicine
Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187 | + My List |
| HOOK | | HOOKIPA Pharma Inc. - Common Stock | | | 3.14% down 9.8% -6.66 | | + Disease: Infectious, Immunology, Cancer fight, Medicine
| + My List |
| HTGM | | HTG Molecular Diagnostics, Inc. - Common Stock | | | 0 | | + Immunology, Medicine
Last highlighted: #HTGM SEC report: HTG MOLECULAR DIAGNOSTICS, INC Statement of changes in beneficial ownership of securities | + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | -4.15% up -8.39% 4.24 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMTX | | Immatics N.V. - Ordinary Shares | | | up -7.67% 7.67 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| IMV | | IMV Inc. - Common Shares | | | up -12.62% 12.62 | | + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma
Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178 | + My List |
| IMVT | | Immunovant, Inc. - Common Stock | | | 2.88% 2.88% 0 | | + Medicine, Immunology
Last highlighted: #IMVT SEC report: Immunovant, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Immunovant, Inc. -- SEC File Number | + My List |
| INMB | | INmune Bio Inc. - Common stock | | | 0.74% down 8.3% -7.56 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | 5.34% down 8.23% -2.89 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| ITOS | | iTeos Therapeutics, Inc. - Common Stock | | | -6.71% -6.71% 0 | | + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine
Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
https://t.co/fsH6i8bthL
15s delayed. | + My List |
| JNCE | | Jounce Therapeutics, Inc. - Common Stock | | | -9.64% -9.64% 0 | | + Immunology, Cancer fight, Medicine
| + My List |
| KRBP | | Kiromic BioPharma, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals | + My List |
| KZR | | Kezar Life Sciences, Inc. - Common Stock | | | 4.31% down 8.62% -4.31 | | + Immunology, Medicine
| + My List |
| MDNA | | Medicenna Therapeutics Corp. - Common Shares | | | 8.26% 8.26% 0 | | + Country: Canada, Immunology
Last highlighted: #MDNA SEC report: Medicenna Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Medicenna Therapeutics Corp. -- SEC File Number 211089394 | + My List |
| MGTA | | Magenta Therapeutics, Inc. - Common Stock | | | -10.77% -10.77% 0 | | + Gene and cell, Cancer fight, Blood, Immunology, Medicine
Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159 | + My List |
| MOR | | MorphoSys AG - American Depositary Shares | | | 2.12% down 9.5% -7.38 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
| + My List |
| MRKR | | Marker Therapeutics, Inc. - Common Stock | | | 0 | | + Immunology, Medicine, Cancer fight
Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01 | + My List |
| NK | | NantKwest, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Immunology
- Bad infrastructure
| + My List |
| NLTX | | Neoleukin Therapeutics, Inc. - Common Stock | | | -8.33% -8.33% 0 | | + Medicine, Immunology
Last highlighted: #NLTX SEC report: Neoleukin Therapeutics, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Neoleukin Therapeutics, Inc. -- SEC File Number 211148247 | + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | 5.85% down 10.17% -4.32 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | 5.71% up -11.88% 17.59 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ONCS | | OncoSec Medical Incorporated - Common Stock | | | 0 | | + Cancer fight, Disease: Oncology, Medicine, Immunology
Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number | + My List |
| ONCY | | Oncolytics Biotech Inc. - Common Shares | | | 7.77% 7.77% 0 | | + Medicine, Cancer fight, Country: Canada, Immunology
Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8 | + My List |
| PAND | | Pandion Therapeutics Inc. - Common stock | | | 0.00% 0 | | + Immunology, Medicine, Organ transplants
Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $PAND #PandionTherapeutics, Inc https://t.co/uNtZ9rhD94 | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | -7.61% -7.61% 0 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PHIO | | Phio Pharmaceuticals Corp. - Common Stock | | | 0 | | + Medicine, Cancer fight, Immunology
Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number | + My List |
| PIRS | | Pieris Pharmaceuticals, Inc. - Common Stock | | | 1.18% down 7.05% -5.87 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight
Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334 | + My List |
| PRVB | | Provention Bio, Inc. - Common Stock | | | 4.71% 4.71% 0 | | + Immunology, Medicine
Last highlighted: #PRVB SEC report: Provention Bio, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Provention Bio, Inc. -- SEC File Number | + My List |
| QDEL | | Quidel Corporation - Common Stock | | | 2.00% 2.00% 0 | | + Medicine, Disease: Infectious, Immunology
Last highlighted: $QDEL 8-K Quidel (22 Apr, 4:53pm)
📰 Quidel Announces Preliminary Revenue for First Quarter 2021
https://t.co/LsfiDmSNca
#QDEL #8K #Quidel #News | + My List |
| SELB | | Selecta Biosciences, Inc. - Common Stock | | | -4.96% down 8.59% -13.55 | | + Biotechnology, Immunology, Biology, Medicine
Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS | + My List |
| SURF | | Surface Oncology, Inc. - Common Stock | | | down 14.57% -14.57 | | + Cancer fight, Immunology, Medicine
Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938 | + My List |
| TNXP | | Tonix Pharmaceuticals Holding Corp. - Common Stock | | | 1.55% down 11.8% -10.25 | | + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)
Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX | + My List |
| TRIL | | Trillium Therapeutics Inc. - Common Shares | | | 0.00% 0 | | + Country: Canada, Cancer fight, Disease: Oncology, Immunology
Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number | + My List |
| VIR | | Vir Biotechnology, Inc. - Common Stock | | | -3.58% -3.58% 0 | | + Immunology, Medicine
Last highlighted: #VIR SEC report: Vir Biotechnology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vir Biotechnology, Inc. -- SEC File Number 211148349 | + My List |
| ZIOP | | ZIOPHARM Oncology Inc - Common Stock | | | 0 | | + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine
| + My List |
| BCTX | | BriaCell Therapeutics Corp. - Common Shares | | | 8.03% 8.03% 0 | | + Cancer fight, Immunology, Medicine, Disease: Oncology
Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540 | + My List |
| BOLT | | Bolt Biotherapeutics, Inc. - Common Stock | | | -10.61% -10.61% 0 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | -15.34% -15.34% 0 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| FSTX | | F-star Therapeutics, Inc. - Common Stock | | | 11.8% 11.8% 0 | | + Immunology, Medicine, Cancer fight, Disease: Oncology
Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number | + My List |
| GTBP | | GT Biopharma, Inc. - Common Stock | | | 16.03% 16.03% 0 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131 | + My List |
| NEXI | | NexImmune, Inc. - Common Stock | | | -9.33% -9.33% 0 | | + Medicine, Immunology
Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $NEXI #NexImmune, Inc. #NexImmune, Inc https://t.co/SsyxY2SUAE | + My List |
| PRTG | | Portage Biotech Inc. - Common Stock | | | -8.8% -8.8% 0 | | + Country: Canada, Immunology, Cancer fight, Disease: Oncology
| + My List |
| RXDX | | Prometheus Biosciences, Inc. - Common Stock | | | -6.42% up -7.04% 0.62 | | + Biotechnology, Medicine, Diagnosing, Immunology
| + My List |
| SCPS | | Scopus BioPharma Inc. - Common Stock | | | 0 | | + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma
Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB | + My List |